RecruitingNot Applicable

A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.

China300 participantsStarted 2021-01-18

Plain-language summary

This study collected clinical, laboratory, and CT parameters of acute patients with acute pulmonary embolism from admission to predict adverse outcomes within 30 days after admission into hospital.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age of ≥ 18 years and a PE diagnosis based on CT pulmonary angiography Exclusion Criteria: * pregnancy * reception of reperfusion treatment before admission * missing data regarding CT parameters, echocardiography, cardiac troponin I (c-Tn I), and N-terminal-pro brain natriuretic peptide (NT-pro BNP) levels.

What they're measuring

Adverse outcomes

Timeframe: 7 days and 30 days

Trial details

NCT IDNCT05098769

SponsorShengjing Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-12-31

Contact for this trial

YIZHUO GAO

+86-18940257523 gaoyizhuo.sy@hotmail.com

View on ClinicalTrials.gov More Pulmonary Embolism and Thrombosis trials